UPDATES FROM INCIDENT COMMAND:
Bamlanivimab “Bam” monoclonal drug for Covid treatment. We have infused 38 patients with this experimental Eli Lilly drug. Our
hospital admission rate is 2.7% for high-risk patients that received this
drug, which is an improvement compared to those high-risk patients who
did not receive the infusion. Only one patient experienced a mild reaction,
which was vomiting at home after the infusion, but the patient fully recovered
afterward without further incidence. The patient that was hospitalized
was here two days and discharged to home and recovered. The hospitalization
was due to Covid illness and
not a reaction to the drug. We have approximately 120 vials remaining.
MHP TESTING STATUS:
Number of NEW positive results: 65 new positive cases since 11/30/2020
- Out of the 65 new positive cases, 8 patients required inpatient care and
57 remained outpatient. Our rapid tests remain limited.
MHP INPATIENT STATUS:
Current number of 3rd floor inpatients: 35 and 7 of those patients are in the Critical Care
Number of available 3rd floor beds: 5
- Currently, we have 22 inpatients that tested positive for COVID.
MHP EMERGENCY DEPT STATUS:
- Number of total ER patients in last 24 hours: 55 patients. We are experiencing
delayed transfers to tertiary facilities because we are waiting on beds
at those tertiary facilities.
Number of vents currently in use and number of vents available:
- We have 3 ventilators in use and 4 BiPAP in use, 1 trilogy unit is in use.
This leaves us with 14 ventilation units available.